New 26BF-2A nuvoDisc Flat Motor Leverages Disc Magnet Technology and Integrated Electronics to Deliver Dynamic Motion Profile

Portescap is expanding its nuvoDisc ™ motor range with the introduction of the 26BF-2A brushless DC slotless flat miniature motor, which features a diameter of 26mm and a body length of 11mm. Benefiting from the usage of disc magnet technology and a cost-optimized design, the 26BF-2A reliably delivers a dynamic motion profile, excellent speed-torque performances, and high-power density in a flat, compact architecture.

The 26BF-2A features two standout characteristics: a larger front ball bearing and integrated electronics. The front ball bearing assembly is larger than most of the standard options available in the market by 1-2mm, thus helping the motor withstand higher axial and radial loads, while the internal integrated electronics ensure that the 26BF-2A provides a plug-and-play solution marked by lower installation time and lesser system complexity. It is also able to deliver a max continuous torque up to 3.5mNm and speeds up to 12,000 rpm.

Designed for space-constrained applications that focus on high speed and low-to-medium torque performance capabilities, the 26BF-2A is an excellent fit for premium tattoo machines, LiDAR, and PAPR (powered air purifying respirator) devices. It can also be an ideal solution for applications that are looking to transition from brush DC to brushless DC flat BLDC solutions, as well as those searching for simple drive solutions.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.